Zhitong Finance App News, ST Renfu (600079.SH) issued an announcement. Hubei Biomedical Industry Technology Research Institute Co., Ltd. (hereinafter referred to as “Research Institute Co., Ltd.”), a wholly-owned subsidiary of the company, recently announced HW201877 capsule phase IIa clinical trial registration information on the drug clinical trial registration and information disclosure platform of the China Drug Administration.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.